Rockefeller Capital Management’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $214K | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $419K | Sell |
|
|||||
|
2024
Q1 | $607K | Sell |
|
|||||
|
2023
Q4 | $19.5M | Buy |
|
|||||
|
2023
Q3 | $787K | Buy |
|
|||||
|
2023
Q2 | $770K | Buy |
|
|||||
|
2023
Q1 | $896K | Sell |
|
|||||
|
2022
Q4 | $3.71M | Sell |
|
|||||
|
2022
Q3 | $4.15M | Buy |
|
|||||
|
2022
Q2 | $4.2M | Sell |
|
|||||
|
2022
Q1 | $3.9M | Sell |
|
|||||
|
2021
Q4 | $5.04M | Buy |
|
|||||
|
2021
Q3 | $2.96M | Buy |
|
|||||
|
2021
Q2 | $638K | Buy |
|
|||||
|
2021
Q1 | $545K | Sell |
|
|||||
|
2020
Q4 | $693K | Buy |
|
|||||
|
2020
Q3 | $190K | Buy |
|
|||||
|
2020
Q2 | $97K | Buy |
|